Copyright
©The Author(s) 2023.
World J Diabetes. Sep 15, 2023; 14(9): 1385-1392
Published online Sep 15, 2023. doi: 10.4239/wjd.v14.i9.1385
Published online Sep 15, 2023. doi: 10.4239/wjd.v14.i9.1385
Factors | Dialysis group (n = 45) | Joint group (n = 49) | χ2 value | P value |
Age (yr) | 2.042 | 0.153 | ||
> 60 | 25 | 20 | ||
≤ 60 | 20 | 29 | ||
Gender | 0.641 | 0.423 | ||
Male | 22 | 28 | ||
Female | 23 | 21 | ||
BMI (kg/m2) | 0.300 | 0.583 | ||
> 25 | 15 | 19 | ||
≤ 25 | 30 | 30 | ||
Course of renal decompensation (yr) | 0.526 | 0.468 | ||
> 2 | 29 | 35 | ||
≤ 2 | 16 | 14 | ||
History of hypertension | 0.512 | 0.474 | ||
Yes | 12 | 10 | ||
No | 33 | 39 | ||
History of hyperlipidemia | 0.566 | 0.451 | ||
Yes | 8 | 6 | ||
No | 37 | 43 | ||
History of smoking | 0.641 | 0.423 | ||
Yes | 22 | 28 | ||
No | 23 | 21 | ||
History of alcoholism | 0.222 | 0.637 | ||
Yes | 6 | 5 | ||
No | 39 | 44 |
- Citation: Ma XY, Sheng YP, Yang XM, Zhang HR, Sun FY. Effects of paricalcitol combined with hemodiafiltration on bone-metabolism-related indexes in patients with diabetic nephropathy and chronic renal failure. World J Diabetes 2023; 14(9): 1385-1392
- URL: https://www.wjgnet.com/1948-9358/full/v14/i9/1385.htm
- DOI: https://dx.doi.org/10.4239/wjd.v14.i9.1385